B. Taş Ozyurtseven Et Al. , "Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience.," BMC oral health , vol.21, pp.272, 2021
Taş Ozyurtseven, B. Et Al. 2021. Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience.. BMC oral health , vol.21 , 272.
Taş Ozyurtseven, B., Serin, I., Nursal, A. F., Pehlivan, S., & Pehlivan, M., (2021). Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience.. BMC oral health , vol.21, 272.
Taş Ozyurtseven, Betul Et Al. "Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience.," BMC oral health , vol.21, 272, 2021
Taş Ozyurtseven, Betul T. Et Al. "Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience.." BMC oral health , vol.21, pp.272, 2021
Taş Ozyurtseven, B. Et Al. (2021) . "Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience.." BMC oral health , vol.21, p.272.
@article{article, author={Betul Taş Ozyurtseven Et Al. }, title={Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience.}, journal={BMC oral health}, year=2021, pages={272} }